These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30651008)

  • 1. Important lessons about testosterone therapy- weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapy.
    Caliber M; Hackett G
    Aging Male; 2020 Dec; 23(5):585-591. PubMed ID: 30651008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and weight loss: the evidence.
    Traish AM
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):313-22. PubMed ID: 25105998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.
    Colleluori G; Chen R; Turin CG; Vigevano F; Qualls C; Johnson B; Mediwala S; Villareal DT; Armamento-Villareal R
    Front Endocrinol (Lausanne); 2020; 11():277. PubMed ID: 32499757
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.
    Saad F; Aversa A; Isidori AM; Gooren LJ
    Curr Diabetes Rev; 2012 Mar; 8(2):131-43. PubMed ID: 22268394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
    Saad F
    Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
    Ng Tang Fui M; Hoermann R; Zajac JD; Grossmann M
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):336-343. PubMed ID: 28561278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogonadism and male obesity: Focus on unresolved questions.
    Grossmann M
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):11-21. PubMed ID: 29683196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism.
    Barnouin Y; Armamento-Villareal R; Celli A; Jiang B; Paudyal A; Nambi V; Bryant MS; Marcelli M; Garcia JM; Qualls C; Villareal DT
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1096-e1110. PubMed ID: 33351921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies.
    Saad F; Yassin A; Doros G; Haider A
    Int J Obes (Lond); 2016 Jan; 40(1):162-70. PubMed ID: 26219417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.
    Salman M; Yassin DJ; Shoukfeh H; Nettleship JE; Yassin A
    Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.
    Grossmann M; Matsumoto AM
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1067-1075. PubMed ID: 28359097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Lapauw B; Kaufman JM
    Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.
    Francomano D; Bruzziches R; Barbaro G; Lenzi A; Aversa A
    J Endocrinol Invest; 2014 Apr; 37(4):401-11. PubMed ID: 24639122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.